干燥综合征眼部和口腔表现的新进展及新治疗是否有效
本文综述原发性干燥综合征(pSS)眼部和口腔受累的诊断与治疗进展。近期突出进展包括泪液渗透压作为干眼病诊断标志物、测量泪液成分和睑板腺结构的新设备及其功能障碍治疗。尽管非侵入性诊断技术(尤其是唾液腺超声)不断涌现,唇腺活检仍具价值。
要点
- 泪液渗透压可作为干眼病诊断的标志物。
- 新设备可测量泪液成分和睑板腺结构并治疗其功能障碍。
- 尽管唾液腺超声等非侵入技术出现,唇腺活检仍有价值。
核心结论
- pSS眼部和口腔受累的诊断与治疗近期有多项进展,包括泪液渗透压用于干眼病诊断、新设备评估泪液成分和睑板腺结构及治疗睑板腺功能障碍。
研究设计与样本
- 本文为综述,回顾pSS眼部和口腔受累诊断与治疗的最新进展。
主要发现
- 泪液渗透压测量是干眼病诊断的标志物。
- 新设备可测量泪液成分和睑板腺结构,并治疗睑板腺功能障碍。
- 尽管非侵入性诊断技术(尤其是唾液腺超声)不断涌现,唇腺活检仍具价值。
临床怎么用
- pSS眼部评估可关注泪液渗透压及睑板腺结构与功能。
- 口腔诊断中唇腺活检仍可考虑,即使有唾液腺超声等非侵入技术。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Primary SS (pSS) is a systemic autoimmune disease characterized by lymphocytic infiltration of the exocrine glands leading to glandular dysfunction, resulting in dryness of the eyes, mouth and other mucosal surfaces. Systemic manifestations also occur in the majority of patients. There has been increasing interest in recent years, with a number of publications regarding the classification criteria, diagnostic tools, disease activity, damage, impact and potential treatments. This article reviews recent advances in the diagnosis and treatment of ocular and oral involvement in pSS. Recent stand-out developments include measurement of tear osmolarity as a marker in dry eye disease diagnosis, new devices measuring tear constituents and meibomian gland structure and treatment of its dysfunction. Lip biopsy is still valuable despite emerging evidence of non-invasive diagnostic techniques, notably salivary gland ultrasound.
引用
- Sutcliffe N, Recchioni A, Hilmi S, et al. What's new in ocular and oral aspects of Sjögren's syndrome and do new treatments work? Rheumatology (Oxford). 2021. PMID: 33369647. doi:10.1093/rheumatology/keaa854
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。